← Back to Clinical Trials
Recruiting NCT06950463

NCT06950463 EFFECT OF CIRCUIT TRAINING ON BONE MINERAL DENSITY IN POST MENOPAUSAL PERIOD

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06950463
Status Recruiting
Phase
Sponsor Cairo University
Condition Post Menopausal
Study Type INTERVENTIONAL
Enrollment 44 participants
Start Date 2025-01-01
Primary Completion 2025-06-01

Eligibility & Interventions

Sex Female only
Min Age 50 Years
Max Age 60 Years
Study Type INTERVENTIONAL
Interventions
Group A (control group): It will be consisted of twenty two post menopausal women who will receive daily dosage of vitamin D3 supplement (600 IU/day) (Schleicher et al., 2016), for 6 week1-Dumbbells (set B08Z7SY6SP ,Gymbit , made in China) :They will be used for the treatment procedures of circuit training for all postmenopausal women in group B. Its surface is coated with vinyl fo

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 44 participants in total. It began in 2025-01-01 with a primary completion date of 2025-06-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study will be conducted to determine the effect of circuit training on bone mineral density in post menopausal period.

Eligibility Criteria

Inclusion Criteria: Post menopausal women (at least 12 months after cessation of menstruation. Their ages will range from 50 -60 years old. Their body mass index (BMI) will be less than 30 Kg/m2. All of them have vitamin D potential deficiency (insufficiency) from 30nmol to 50nmol . Their T-score on DEXA will range from -1.1 to -2.4 indicates osteopenia or low bone density. They must be able to ambulate independently. All of them must be sedentary life style. Exclusion Criteria: All women will be excluded if they have one of the following criteria: Thyroid, kidney and liver dysfunction. Cardiovascular diseases, severe anemia, uncontrolled diabetes mellitus. Any chest surgery, chronic obstructive pulmonary disease, malignancy. Renal failure, myocardial infarction, myasthenia gravis, hyperthyroidism. Hemorrhage, acute viral disease, acute tuberculosis, mental disorders, or those with pacemakers. Musculoskeletal disorders or women who received corticosteroids in the last 6 months prior to the study.

Contact & Investigator

Central Contact

Noha Lotfy ElShater, Bachelor's degree

✉ nohalotfy1992@gmail.com

📞 +201010534226

Frequently Asked Questions

Who can join the NCT06950463 clinical trial?

This trial is open to female participants only, aged 50 Years or older, up to 60 Years, studying Post Menopausal. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06950463 currently recruiting?

Yes, NCT06950463 is actively recruiting participants. Contact the research team at nohalotfy1992@gmail.com for enrollment information.

Where is the NCT06950463 trial being conducted?

This trial is being conducted at Cairo, Egypt.

Who is sponsoring the NCT06950463 clinical trial?

NCT06950463 is sponsored by Cairo University. The trial plans to enroll 44 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology